Mood changes with deep brain stimulation of STN and GPi: results of a pilot study
Open accessThe DOI matches its Crossref record.
Abstract
Background CDC guidelines recommend gentamicin for the treatment of gonorrhea in cephalosporin-allergic patients. The efficacy of gentamicin in the treatment of pharyngeal gonorrhea, which is often undiagnosed, is uncertain. Methods Between September 2018 – March 2019, we enrolled MSM with NAAT-diagnosed pharyngeal gonorrhea in a single-arm, unblinded clinical trial. Men received a single 360 mg intramuscular (IM) dose of gentamicin at enrollment and underwent test-of-cure (TOC) by culture 4–7 days later. The study measured creatinine at enrollment and TOC, serum gentamicin concentration post-dose to establish peak concentration (Cmax), and standard antimicrobial minimal inhibitory concentrations (MIC). The trial was designed to establish a point estimate for the efficacy of gentamicin for pharyngeal gonorrhea. We planned to enroll 50 evaluable subjects; assuming that gentamicin was 80% efficacious, the trial would establish a 95% confidence interval of 66%-90%. We planned interim analyses at n=10 and n=25. Results The study was stopped early due to poor efficacy. Of 13 enrolled men, 10 were evaluable, and only two (20%, 95%CI: 2.5% - 55.6%) were cured. Of 2 concomitant rectal infections, both were cured. Efficacy was not associated with gentamicin Cmax (p=0.809) or MIC (p= 0.429). No participants experienced renal insufficiency; average creatinine percent change was 5% (range: -7%, 21%). Six (46%) subjects experienced headache; all deemed unrelated to treatment. On a scale of 0–10, mean injection pain was 2 (range: 1–7). Among subjects with history of bicillin (n=7) and/or ceftriaxone (n=8) IM injections, 86% believed IM gentamicin to be less painful than bicillin and 75% believed it was more painful than ceftriaxone. Conclusion 360 mg of gentamicin failed to eradicate N. gonorrhoeae from the pharynx. Caution should be used when using the CDC’s current alternative therapy (gentamicin 240 mg plus azithromycin 2g) given increases in azithromycin resistance and gentamicin’s poor efficacy at the pharynx. Disclosure No significant relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Okun, M. S., Fernandez, H. H., Wu, S. S., Kirsch‐Darrow, L., Bowers, D., Bova, F., Suelter, M., Jacobson, C. E., Wang, X., Gordon, C. W., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21596 · Cited by 545
Self-citationDeep brain stimulation for refractory obsessive-compulsive disorder
Abelson, J. L., Curtis, G. C., Sagher, O., Albucher, R. C., Harrigan, M., Taylor, S. F., Martis, B., & Giordani, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.042 · Cited by 522
Deep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Deep brain stimulation: Preoperative issues
Lang, A. E., Houeto, J.-L., Krack, P., Kubu, C., Lyons, K. E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A. I., et al. (2006) · Movement Disorders · doi:10.1002/mds.20955 · Cited by 308
Appleby, B. S., Duggan, P. S., Regenberg, A., & Rabins, P. V. (2007) · Movement Disorders · doi:10.1002/mds.21551 · Cited by 291
Metadata
- Authors
- Okun, M. S.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2003-11-01
- Volume
- 74
- Issue
- 11
- Pages
- 1584-1586
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2156749100
- Cited by
- 101
- References
- 0
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. https://app.cochat.ai/papers/10.1136/jnnp.74.11.1584
- The paper
- Okun, M. S. (2003). Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.11.1584
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.